Nothing Special   »   [go: up one dir, main page]

FR2853908B1 - Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant - Google Patents

Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant

Info

Publication number
FR2853908B1
FR2853908B1 FR0304745A FR0304745A FR2853908B1 FR 2853908 B1 FR2853908 B1 FR 2853908B1 FR 0304745 A FR0304745 A FR 0304745A FR 0304745 A FR0304745 A FR 0304745A FR 2853908 B1 FR2853908 B1 FR 2853908B1
Authority
FR
France
Prior art keywords
bifidobacterium
immunomodulator
culture
same
product obtained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0304745A
Other languages
English (en)
Other versions
FR2853908A1 (fr
Inventor
Valerie Petay
Francis Lecroix
Emmanuel Perrin
Charles Gontier
Jean Pierre Blareau
Marie Benedicte Romond
Elisabeth Singer
Marie Francoise Odou
Mullie Catherine Demailly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gervais Danone SA
Original Assignee
Gervais Danone SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gervais Danone SA filed Critical Gervais Danone SA
Priority to FR0304745A priority Critical patent/FR2853908B1/fr
Priority to EP04742462A priority patent/EP1615657A1/fr
Priority to PCT/FR2004/000875 priority patent/WO2004093899A1/fr
Publication of FR2853908A1 publication Critical patent/FR2853908A1/fr
Application granted granted Critical
Publication of FR2853908B1 publication Critical patent/FR2853908B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR0304745A 2003-04-16 2003-04-16 Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant Expired - Fee Related FR2853908B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0304745A FR2853908B1 (fr) 2003-04-16 2003-04-16 Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant
EP04742462A EP1615657A1 (fr) 2003-04-16 2004-04-08 Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant
PCT/FR2004/000875 WO2004093899A1 (fr) 2003-04-16 2004-04-08 Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0304745A FR2853908B1 (fr) 2003-04-16 2003-04-16 Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant

Publications (2)

Publication Number Publication Date
FR2853908A1 FR2853908A1 (fr) 2004-10-22
FR2853908B1 true FR2853908B1 (fr) 2005-06-03

Family

ID=33041902

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0304745A Expired - Fee Related FR2853908B1 (fr) 2003-04-16 2003-04-16 Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant

Country Status (3)

Country Link
EP (1) EP1615657A1 (fr)
FR (1) FR2853908B1 (fr)
WO (1) WO2004093899A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2876702B1 (fr) * 2004-10-14 2010-09-17 Univ Lille Ii Droit & Sante Procede de preparation d'une macromolecule d'origine bacterienne, macromolecule ainsi obtenue et utilisation de ladite macromolecule pour prevenir et traiter les rhumatismes inflammatoires
EP1776877A1 (fr) 2005-10-21 2007-04-25 N.V. Nutricia Méthode de stimulation de la flore intestinale
CN102065867A (zh) * 2008-06-13 2011-05-18 N.V.努特里奇亚 预防感染的营养物
IT1398553B1 (it) * 2010-03-08 2013-03-01 Probiotical Spa Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
WO2013187755A1 (fr) 2012-06-14 2013-12-19 N.V. Nutricia Formule fermentée avec oligosaccharides non digestibles pour nourrissons
BR112015009579B1 (pt) 2012-11-02 2020-04-28 Nutricia Nv uso de glutamina, bifidobacterium breve e pelo menos um oligossacarídeo não digerível, e composição nutricional
WO2014200334A1 (fr) 2013-06-14 2014-12-18 N.V. Nutricia Composition synbiotique pour le traitement d'infections chez des patients allergiques
CN105848499A (zh) 2013-11-04 2016-08-10 N·V·努特里奇亚 含有不可消化寡糖的发酵配方物
WO2015160234A1 (fr) 2014-04-17 2015-10-22 N.V. Nutricia Composition d'amélioration de cerveau
WO2016148562A1 (fr) 2015-03-18 2016-09-22 N.V. Nutricia Procédé pour induire une tolérance orale par administration d'un peptide dérivé de bêta-lactoglobuline en combinaison avec un probiotique
WO2017114900A1 (fr) 2015-12-29 2017-07-06 N.V. Nutricia Préparation pour nourrissons fermentée comportant des oligosaccharides non digestibles
ES2821914T3 (es) 2016-05-10 2021-04-28 Nutricia Nv Usos de un preparado fermentado para lactantes
PL3454674T3 (pl) 2016-05-10 2021-06-14 N.V. Nutricia Sposoby stosowania fermentowanej mieszanki mlecznej dla niemowląt
WO2018143793A1 (fr) 2017-02-01 2018-08-09 N.V. Nutricia Modulation alimentaire du fonctionnement du cerveau
WO2019002612A1 (fr) 2017-06-30 2019-01-03 N.V. Nutricia Composition symbiotique pour la prévention de troubles métaboliques
EP3645023B1 (fr) 2017-06-30 2022-09-14 N.V. Nutricia Composition symbiotique de prévention de l'hyperinsulinémie et de la résistance à l'insuline
CN112384227A (zh) 2018-02-09 2021-02-19 N·V·努特里奇亚 含有不可消化寡糖的发酵配方物
CN111698993A (zh) 2018-02-09 2020-09-22 N·V·努特里奇亚 含有不可消化寡糖的发酵配方物
WO2019212329A1 (fr) 2018-04-30 2019-11-07 N.V. Nutricia Formule avec des peptides de bêta-lactoglobuline spécifiques
WO2019212330A1 (fr) 2018-04-30 2019-11-07 N.V. Nutricia Formule avec un peptide bêta-lactoglobuline spécifique
US20220187307A1 (en) 2018-05-22 2022-06-16 N.V. Nutricia Biomarkers for improving nutrion for infants at risk
EP3911341B1 (fr) 2019-01-16 2022-12-28 N.V. Nutricia Formule fermentée comportant des oligosaccharides non digestibles pour l'utilisation dans une infection à rotavirus
CN113423288A (zh) 2019-02-04 2021-09-21 N·V·努特里奇亚 用于睡眠改善的含有不可消化的低聚糖的发酵配方物
WO2020229689A1 (fr) 2019-05-15 2020-11-19 N.V. Nutricia Préparation pour nourrissons fermentée pour améliorer le développement intestinal
US20220256904A1 (en) 2019-06-13 2022-08-18 N.V. Nutricia Process for manufacturing a fermented infant formula product
WO2021091369A1 (fr) 2019-11-07 2021-05-14 N.V. Nutricia Hydrolysat étendu de protéine de lactosérum avec des peptides tolérogènes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2124060T5 (es) * 1992-07-06 2002-12-16 Nestle Sa Bacteria lactica.
FR2795917B1 (fr) * 1999-07-06 2001-08-31 Gervais Danone Sa Procede de preparation d'un produit lacte immunostimulant et ses applications

Also Published As

Publication number Publication date
WO2004093899A1 (fr) 2004-11-04
FR2853908A1 (fr) 2004-10-22
EP1615657A1 (fr) 2006-01-18

Similar Documents

Publication Publication Date Title
FR2853908B1 (fr) Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant
Yadav et al. Food-grade single-cell protein production, characterization and ultrafiltration recovery of residual fermented whey proteins from whey
BR9814641A (pt) Processamento do ácido láctico; métodos; arranjos; e, produtos
RU2006140134A (ru) Способ получения ингибиторов дипептидил iv
DK1013765T4 (da) Fremgangsmåde til frembringelse af L-aminosyrer
HU191746B (en) Process for producing new proteins for diminishing level of cholesterol in the blood and pharmaceutical compositions containing them
DE50001184D1 (de) Verfahren zur herstellung von lösemittelfreier alpha-liponsäure
ATE465998T1 (de) Verfahren zur herstellung und reinigung von 1,7'- dimethyl-2'-propyl-2,5'-bi-1h-benzimidazol
DE60225004D1 (de) Verfahren zur Herstellung von Glutathion
ATE207114T1 (de) Herstellung von hefeerzeugnissen aus laktose enthaltenden substraten
BR0005798A (pt) Processo para preparação fermentativa del-aminoácidos usando bactérias corineforme
ATE374831T1 (de) Verfahren zur fermentativen herstellung von l- aminosäuren durch verstärkung des tkt-gens
JPS5923796B2 (ja) Ｌ−セリンの製造法
JPS6342686A (ja) プロテア−ゼの製造法
AU2003243925A8 (en) Mpg added to fermentation
NO136204B (fr)
JP6629512B2 (ja) トルラ酵母由来グルコシルセラミド含有コラーゲン産生促進組成物
JPS62289198A (ja) ヒアルロン酸の新規製造方法
US3259550A (en) Production of neuraminidase
JPH1042886A (ja) 微生物によるβ−アラニンの製造法
JP3737252B2 (ja) 上皮細胞増殖因子活性を有するタンパク質の回収精製法
JPS6349097A (ja) イプシロン−ポリ−ｌ−リシンの製造法
JPS62107785A (ja) 新規酵素、その製造法およびｎ−（ｌ−アスパルチル−１）−ｌ−フエニルアラニンメチルエステル製造へのその応用
JPS63129991A (ja) ヒアルロン酸の製法
JPH0662880A (ja) ４−ヒドロキシ−ｌ−プロリンの製造法

Legal Events

Date Code Title Description
CA Change of address
ST Notification of lapse

Effective date: 20131231